serena williams and glp 1 Inside Williams' partnership with Ro for GLP-1s Wimbledon 2026: Why Serena Williams'

Weekly self-injection under the skin (subcutaneous) Gradual dose increase to minimize side effects Regular follow-ups to monitor progress and adjust treatment Support with nutrition and lifestyle coaching Common Side Effects Nausea Diarrhea or constipation Mild stomach discomfort Side effects usually lessen after the first few weeks

doi: 10.1016/j.jad.2024.08.179

BMI Over 35 No additional questions

Retatrutide (GLP3) is a triple agonist adding glucagon for energy expenditure and fat burning, with phase 2/3 trials showing 2428.7% average weight loss over 4868 weekspotentially double semaglutides impact. What weight loss results have retatrutide shown in trials

For some patients, a GLP-1 or related medication may be appropriate

Curtis completed his medical degree at Ross University and pursued a residency in internal medicine and advanced training in infectious disease at Drexel University (Medical College of Pennsylvania-Hahnemann)